查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1788498

持續血糖監測市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 243 Pages | 商品交期: 2-10個工作天內

價格

持續血糖監測市場-報告範圍

TMR 的全球持續血糖監測市場報告研究了過去和當前的成長趨勢和機遇，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2019 年至 2035 年期間全球持續血糖監測市場的收入，以 2025 年為基準年，2035 年為預測年。該報告還提供了 2025 年至 2035 年全球持續血糖監測市場的年複合成長率(CAGR%)。

本報告經過廣泛調查後編寫。主要研究工作包括分析師對關鍵意見領袖、產業領導者和輿論領袖進行訪談。次要研究則參考了主要廠商的產品資料、年度報告、新聞稿和相關文件，以了解二輪車導航顯示器市場。

市場概況
2024 年的市場價值 58億美元
2035年的市場價值 126億美元
複合年成長率 7.4%

本報告深入探討了全球二輪車導航顯示器市場的競爭格局。該報告確定了全球持續血糖監測市場的主要參與者，並根據不同屬性對每位參與者進行了分析。本報告對全球持續血糖監測市場參與者的屬性進行了分析，內容包括公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020年至2035年全球連續血糖監測市場分析與預測

第5章：關鍵見解

  • 全球主要國家疾病盛行率及發生率
  • 重要產業事件（合併、收購、合作、協作等）
  • 技術進步
  • 波特五力分析
  • PESTEL分析
  • 價值鏈分析
  • 定價分析（品牌定價、按地區/國家分類的平均售價）
  • 各主要國家的監管情況
  • 研發趨勢
  • 新市場進入者的市場進入策略

第6章：全球市場分析與預測：依類型

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按類型，2020 年至 2035 年
    • 即時CGM
    • 間歇掃描CGM
  • 市場吸引力分析：按類型

第7章：全球市場分析與預測：依組成部分

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按組件，2020 年至 2035 年
    • 感應器
    • 發射機
    • 接收者
  • 市場吸引力分析：按組件

第8章：全球市場分析及預測：依年齡層

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：依年齡段，2020年至2035年
    • 孩子們
    • 成年人
  • 市場吸引力分析：依年齡段

第9章：全球市場分析與預測：依指標

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按適應症，2020 年至 2035 年
    • 1型糖尿病
    • 2型糖尿病
    • 其他
  • 市場吸引力分析：按適應症

第10章：全球市場分析與預測：依最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2020 年至 2035 年
    • 醫院和診所
    • 家庭護理設置
    • 其他
  • 市場吸引力分析：按最終用戶

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020年至2035年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區
  • 介紹
    • 主要發現
  • 市場價值預測：按類型，2020 年至 2035 年
    • 即時CGM
    • 間歇掃描CGM
  • 市場價值預測：按組件，2020 年至 2035 年
    • 感應器
    • 發射機
    • 接收者
  • 市場價值預測：依年齡段，2020年至2035年
    • 孩子們
    • 成年人
  • 市場價值預測：按適應症，2020 年至 2035 年
    • 1型糖尿病
    • 2型糖尿病
    • 其他
  • 市場價值預測：按最終用戶，2020 年至 2035 年
    • 醫院和診所
    • 家庭護理設置
    • 其他
  • 市場價值預測：按國家/地區，2020 年至 2035 年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按類型
    • 按組件
    • 按年齡層
    • 按適應症
    • 按最終用戶
    • 按國家/地區

第13章：歐洲市場分析與預測

第14章：亞太市場分析與預測

第15章：拉丁美洲市場分析與預測

第16章：中東和非洲市場分析與預測

第 17 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2024年）
  • 公司簡介
    • Dexcom, Inc.
    • Abbott
    • Medtronic
    • Ypsomed AG
    • Senseonics Holdings, Inc.
    • A. Menarini Diagnostics Srl
    • Signos, Inc.
    • F. Hoffmann-La Roche Ltd
    • Nemaura
    • Bionime Corporation
    • Intelligo BV.
Product Code: TMRGL1169

Continuous Glucose Monitoring Market - Scope of Report

TMR's report on the global Continuous Glucose Monitoring Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Continuous Glucose Monitoring Market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Continuous Glucose Monitoring Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024US$ 5.8 Bn
Market Value in 2035US$ 12.6 Bn
CAGR7.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Continuous Glucose Monitoring Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Continuous Glucose Monitoring Market profiled in this report.

Key Questions Answered in Global Continuous Glucose Monitoring Market Report:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global two-wheeler navigation display market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Continuous Glucose Monitoring Market - Research Objectives and Research Approach

The comprehensive report on the global Continuous Glucose Monitoring Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Continuous Glucose Monitoring Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Continuous Glucose Monitoring Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Continuous Glucose Monitoring Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Disease Prevalence & Incidence Rate globally with key countries
  • 5.2. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.3. Technological Advancements
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTEL Analysis
  • 5.6. Value Chain Analysis
  • 5.7. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
  • 5.8. Regulatory Scenario by Key Country/Region
  • 5.9. Research and Development Trends
  • 5.10. Go-to-Market Strategy for New Market Entrants

6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020 to 2035
    • 6.3.1. Real-Time CGM
    • 6.3.2. Intermittently Scanned CGM
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Component

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Component, 2020 to 2035
    • 7.3.1. Sensor
    • 7.3.2. Transmitter
    • 7.3.3. Receiver
  • 7.4. Market Attractiveness Analysis, by Component

8. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Age Group

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Age Group, 2020 to 2035
    • 8.3.1. Children
    • 8.3.2. Adults
  • 8.4. Market Attractiveness Analysis, by Age Group

9. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Indication, 2020 to 2035
    • 9.3.1. Type 1 Diabetes
    • 9.3.2. Type 2 Diabetes
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Continuous Glucose Monitoring Market Analysis and Forecast, by End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2020 to 2035
    • 10.3.1. Hospitals & Clinics
    • 10.3.2. Homecare Settings
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by End-user

11. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2020 to 2035
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region
  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020 to 2035
    • 12.2.1. Real-Time CGM
    • 12.2.2. Intermittently Scanned CGM
  • 12.3. Market Value Forecast, by Component, 2020 to 2035
    • 12.3.1. Sensor
    • 12.3.2. Transmitter
    • 12.3.3. Receiver
  • 12.4. Market Value Forecast, by Age Group, 2020 to 2035
    • 12.4.1. Children
    • 12.4.2. Adults
  • 12.5. Market Value Forecast, by Indication, 2020 to 2035
    • 12.5.1. Type 1 Diabetes
    • 12.5.2. Type 2 Diabetes
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by End-user, 2020 to 2035
    • 12.6.1. Hospitals & Clinics
    • 12.6.2. Homecare Settings
    • 12.6.3. Others
  • 12.7. Market Value Forecast, by Country, 2020 to 2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type
    • 12.8.2. By Component
    • 12.8.3. By Age Group
    • 12.8.4. By Indication
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Continuous Glucose Monitoring Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020 to 2035
    • 13.2.1. Real-Time CGM
    • 13.2.2. Intermittently Scanned CGM
  • 13.3. Market Value Forecast, by Component, 2020 to 2035
    • 13.3.1. Sensor
    • 13.3.2. Transmitter
    • 13.3.3. Receiver
  • 13.4. Market Value Forecast, by Age Group, 2020 to 2035
    • 13.4.1. Children
    • 13.4.2. Adults
  • 13.5. Market Value Forecast, by Indication, 2020 to 2035
    • 13.5.1. Type 1 Diabetes
    • 13.5.2. Type 2 Diabetes
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by End-user, 2020 to 2035
    • 13.6.1. Hospitals & Clinics
    • 13.6.2. Homecare Settings
    • 13.6.3. Others
  • 13.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.7.1. Germany
    • 13.7.2. UK
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. The Netherlands
    • 13.7.7. Switzerland
    • 13.7.8. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type
    • 13.8.2. By Component
    • 13.8.3. By Age Group
    • 13.8.4. By Indication
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020 to 2035
    • 14.2.1. Real-Time CGM
    • 14.2.2. Intermittently Scanned CGM
  • 14.3. Market Value Forecast, by Component, 2020 to 2035
    • 14.3.1. Sensor
    • 14.3.2. Transmitter
    • 14.3.3. Receiver
  • 14.4. Market Value Forecast, by Age Group, 2020 to 2035
    • 14.4.1. Children
    • 14.4.2. Adults
  • 14.5. Market Value Forecast, by Indication, 2020 to 2035
    • 14.5.1. Type 1 Diabetes
    • 14.5.2. Type 2 Diabetes
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by End-user, 2020 to 2035
    • 14.6.1. Hospitals & Clinics
    • 14.6.2. Homecare Settings
    • 14.6.3. Others
  • 14.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. South Korea
    • 14.7.6. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type
    • 14.8.2. By Component
    • 14.8.3. By Age Group
    • 14.8.4. By Indication
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Continuous Glucose Monitoring Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2020 to 2035
    • 15.2.1. Real-Time CGM
    • 15.2.2. Intermittently Scanned CGM
  • 15.3. Market Value Forecast, by Component, 2020 to 2035
    • 15.3.1. Sensor
    • 15.3.2. Transmitter
    • 15.3.3. Receiver
  • 15.4. Market Value Forecast, by Age Group, 2020 to 2035
    • 15.4.1. Children
    • 15.4.2. Adults
  • 15.5. Market Value Forecast, by Indication, 2020 to 2035
    • 15.5.1. Type 1 Diabetes
    • 15.5.2. Type 2 Diabetes
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by End-user, 2020 to 2035
    • 15.6.1. Hospitals & Clinics
    • 15.6.2. Homecare Settings
    • 15.6.3. Others
  • 15.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Argentina
    • 15.7.4. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type
    • 15.8.2. By Component
    • 15.8.3. By Age Group
    • 15.8.4. By Indication
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type, 2020 to 2035
    • 16.2.1. Real-Time CGM
    • 16.2.2. Intermittently Scanned CGM
  • 16.3. Market Value Forecast, by Component, 2020 to 2035
    • 16.3.1. Sensor
    • 16.3.2. Transmitter
    • 16.3.3. Receiver
  • 16.4. Market Value Forecast, by Age Group, 2020 to 2035
    • 16.4.1. Children
    • 16.4.2. Adults
  • 16.5. Market Value Forecast, by Indication, 2020 to 2035
    • 16.5.1. Type 1 Diabetes
    • 16.5.2. Type 2 Diabetes
    • 16.5.3. Others
  • 16.6. Market Value Forecast, by End-user, 2020 to 2035
    • 16.6.1. Hospitals & Clinics
    • 16.6.2. Homecare Settings
    • 16.6.3. Others
  • 16.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type
    • 16.8.2. By Component
    • 16.8.3. By Age Group
    • 16.8.4. By Indication
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. Dexcom, Inc.
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Abbott
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Medtronic
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Ypsomed AG
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Senseonics Holdings, Inc.
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. A. Menarini Diagnostics S.r.l.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Signos, Inc.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. F. Hoffmann-La Roche Ltd
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Nemaura
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Bionime Corporation
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Intelligo BV.
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments

List of Tables

  • Table 01: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 02: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
  • Table 03: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
  • Table 04: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 05: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 06: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 08: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 09: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
  • Table 10: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
  • Table 11: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 12: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 13: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 15: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
  • Table 16: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
  • Table 17: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 18: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 19: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 20: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 21: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
  • Table 22: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
  • Table 23: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 24: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 27: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
  • Table 28: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
  • Table 29: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 30: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 31: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 32: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 33: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
  • Table 34: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
  • Table 35: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 36: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 02: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 03: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Real-Time CGM, 2020 to 2035
  • Figure 04: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Intermittently Scanned CGM, 2020 to 2035
  • Figure 05: Global Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
  • Figure 06: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
  • Figure 07: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Sensor, 2020 to 2035
  • Figure 08: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Transmitter, 2020 to 2035
  • Figure 09: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Receiver, 2020 to 2035
  • Figure 10: Global Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
  • Figure 11: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
  • Figure 12: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Children, 2020 to 2035
  • Figure 13: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Adults, 2020 to 2035
  • Figure 14: Global Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 15: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 16: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Type 1 Diabetes, 2020 to 2035
  • Figure 17: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Type 2 Diabetes, 2020 to 2035
  • Figure 18: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 19: Global Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 20: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 21: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Hospitals & Clinics, 2020 to 2035
  • Figure 22: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Homecare Settings, 2020 to 2035
  • Figure 23: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 24: Global Continuous Glucose Monitoring Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 25: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 26: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 27: North America Continuous Glucose Monitoring Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 28: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 29: North America Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 30: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 31: North America Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
  • Figure 32: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
  • Figure 33: North America Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
  • Figure 34: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
  • Figure 35: North America Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 36: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 37: North America Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 38: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 39: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 40: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 41: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 42: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 43: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 44: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
  • Figure 45: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
  • Figure 46: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
  • Figure 47: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
  • Figure 48: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 49: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 50: Europe Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 51: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 52: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 53: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 54: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 55: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 56: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 57: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
  • Figure 58: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
  • Figure 59: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
  • Figure 60: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
  • Figure 61: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 62: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 63: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 64: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 65: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 66: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 67: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 68: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 69: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 70: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 an
  • Figure 71: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
  • Figure 72: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
  • Figure 73: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
  • Figure 74: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 75: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 76: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 77: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 78: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 79: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 80: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 81: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 82: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 83: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
  • Figure 84: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
  • Figure 85: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
  • Figure 86: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
  • Figure 87: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 88: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 89: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 90: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035